Heron Therapeutics
HRTX
#10234
Rank
S$69.17 M
Marketcap
S$0.36
Share price
-0.74%
Change (1 day)
-74.40%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2026 (TTM): S-$0.24

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is S-$0.24. In 2025 the company made an earnings per share (EPS) of S-$0.15 a decrease over its 2024 EPS that were of S-$0.12.

EPS history for Heron Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.2458.41%
2025S-$0.1533.33%
2024S-$0.12
2022S-$2.23-23.11%
2021S-$2.90-10%
2020S-$3.22-0%
2019S-$3.221.21%
2018S-$3.18
2016S-$5.8654.76%
2015S-$3.791.73%
2014S-$3.72-16.23%
2013S-$4.4491.67%
2012S-$2.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
S-$1.58 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
S$0.45-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.34-1,463.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S-$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
S-$8.63 3,426.32%๐Ÿ‡บ๐Ÿ‡ธ USA